From: Is routine karyotyping required in prenatal samples with a molecular or metabolic referral?
Case no | Karyotype STC | Karyotype LTC | ≥ 36 years | Karyotype AF | Follow-up testing | Type | Pregnancy follow-up and clinical outcome | DNA analysis or metabolic testing |
---|---|---|---|---|---|---|---|---|
Aneuploidy in STC and LTC | Â | Â | Â | Â | Â | Â | Â | Â |
1 | 47, XXY[3] | 47, XXY[9] | no | Â | - | Â | TOP | not affected |
2 | FISH(13,18)×2, (X, Y)×1, (21)×3 | 47, XY, +21[8] | yes |  | - |  | TOP | not determined |
3 | 47, XY, +21[2] | 47, XY, +21[8] | no | Â | - | Â | TOP | not determined |
4 | 47, XXY[4] | 47, XXY[8] | no | Â | - | Â | TOP | not affected |
5 | 47, XY, +18[3] | 47, XY, +18[11] | yes | Â | - | Â | TOP | not determined |
6 | 47, XY, +21[4] | 47, XY, +21[8] | yes | Â | - | Â | TOP | not determined |
Aberration in STC, not in LTC | Â | Â | Â | Â | Â | Â | Â | Â |
7 | 47, XX, +3[3]/46, XX[4] | 46, XX[11] | yes | Â | AF 46, XX | CPM I | continued | not affected |
8 | 45, X[4] | 46, XX[29] | no | Â | AF 46, XX | CPM I | continued | not affected |
9 | 47, XY, +15[2]/46, XY[2] | 46, XY[29] | no | Â | AF 46, XY, no UPD(15) | CPM I | continued | not affected |
10 | 48, XY, +3, +21[5]/ 46, XY[6] | 46, XY[16] | no | Â | AF 46, XY | CPM I | continued | not affected |